Grup de recerca de biomarcadors en càncer (GReBiC)
- Nombre de publicacions
- 495
Publicacions
-
Rivera, F; Romero, C; Jimenez-Fonseca, P; Izquierdo-Manuel, M; Salud, A; Martínez E; Jorge, M; Arrazubi, V; Méndez JC; García-Alfonso P; Reboredo, M; Barriuso, J; Mu?oz-Unceta, N; Jimeno, R; López C
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial (vol 83, pg 1175, 2019)
CANCER CHEMOTHERAPY AND PHARMACOLOGY 84 1365-1365. .
-
MORALES MURILLO, SERAFIN
Clinical Benefit with Palbociclib in Estrogen Receptor-Positive, Her2-Negative Metastatic Breast Cancer: New Concepts
Clinics of Oncology 2 -. .
-
Ciruelos, EM; Diaz, MN; Isla, MD; Lopez, R; Bernabe, R; Gonzalez, E; Cirauqui, B; Coves, J; Morales, S; Arcediano, A; Barneto, I; Cerezuela, P; Illarramendi, JJ; Morales, C; Ponce, S
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer
EUROPEAN JOURNAL OF CANCER CARE 28 -. .
-
Fernandez-Martos, C; Pericay, C; Losa, F; Garcia-Carbonero, R; Layos, L; Rodriguez-Salas, N; Martin-Richard, M; Alonso-Orduna, V; Vera, R; Gallego, J; Capdevila, J; Salud, A; Nogue, M; Maurel, J; Guash, I; Montagut, C; Lopez, C; Macias, I; Jain, RK; Garcia-Albeniz, X
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma The GEMCAD 1402 Randomized Clinical Trial
JAMA Oncology 5 1566-1573. .
-
García-Albéniz X; Alonso, V; Escudero, P; Méndez M; Gallego, J; Rodríguez JR; Salud, A; Fernández-Plana J; Manzano, H; Zanui, M; Falc?, E; Feliu, J; Gil, M; Fernández-Martos C; Bohn, U; Alonso, C; Calderero, V; Rojo, F; Cuatrecasas, M; Maurel, J
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)
Oncologist 24 1115-1122. .
-
Roman-Canal, B; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Gonzalez, E; Ojanguren, A; Recuero, JL; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Porcel, JM; Matias-Guiu, X; Colas, E
EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer
SCIENTIFIC REPORTS 9 15057-15057. .
-
Porcel, JM
Dual intracavitary therapy for pleural infections: leaving reluctance behind
EUROPEAN RESPIRATORY JOURNAL 54 -. .
-
Porcel, JM; Esquerda, A; Bielsa, S; Novell, A; Sorolla, MA; Gatius, S; Zamora, C; Vidal, S; Salud, A
Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions
RESPIROLOGY 24 799-804. .
-
Porcel, JM
Ultrasound-based elastography: "hard" to implement in the pleural effusion work-up?
EUROPEAN RESPIRATORY JOURNAL 54 -. .
-
Porcel, JM
Diagnosis and characterization of malignant effusions through pleural fluid cytological examination
Current Opinion in Pulmonary Medicine 25 362-368. .
-
Roman-Canal, B; Tarragona, J; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Sierra, JE; Rufas, M; Gonzalez, E; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E
EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer
Journal Of Translational Medicine 17 208-208. .
-
Carrato, A; Benavides, M; Massuti, B; Ferreiro-Monteagudo, R; García Alfonso P; Falco, E; Reboredo, M; Cano, T; Gallego, J; Vieitez, JM; Layos, L; Salud, A; Polo, E; Dotor, E; Duran-Ogalla, G; Rodriguez-Garrote, M; Calvo, A; Grande, E; Aranda, E
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Bmc Cancer 19 533-533. .
